NEW YORK, June 5-The combinatorial biology company Phylos is working with Upstate, Inc to develop binding protein reagents for a new protein chip, the company said today.
In this arrangement, Upstate will market the chip. Phylos will receive research funding and milestone payments and royalties, if applicable.
Upstate, based in Waltham, Mass., develops drug discovery reagents, kits, and services based on cell signaling. It has kits for kinase activity screening and for Luminex's detection system.
Phylos is developing protein libraries for research into binding proteins, tissue proteomics, and therapeutics. The company is based in Lexington, Mass.
For further information, see the company press release.